$ARMC
Un Monde International Ltd.

2022 Q4 Form 10-Q Financial Statement

#000168316822007600 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.450K $15.47K $8.600K
YoY Change -44.92% 79.88%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $6.450K $15.47K $8.600K
YoY Change -44.92% 79.86%
Operating Profit -$15.47K -$8.603K
YoY Change 79.8%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$6.450K -$15.47K -$8.600K
YoY Change -44.92% 79.88%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.450K -$15.47K -$8.600K
YoY Change -44.92% 79.86%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$1.131K
COMMON SHARES
Basic Shares Outstanding 6.493M shares 6.493M shares 7.603M shares
Diluted Shares Outstanding 6.493M shares 7.603M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00 $0.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $102.7K $79.87K $41.43K
YoY Change 64.85% 92.78%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $102.7K $96.27K $54.37K
YoY Change 55.47% 77.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $102.7K $96.27K $54.37K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $102.7K $96.27K $54.37K
YoY Change 55.47% 77.06%
SHAREHOLDERS EQUITY
Retained Earnings -$2.426M -$2.420M
YoY Change 1.53%
Common Stock $6.493K $6.493K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$102.7K -$96.27K -$54.37K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$6.450K -$15.47K -$8.600K
YoY Change -44.92% 79.86%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$7.740K -$16.87K -$10.50K
YoY Change -62.93% 60.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.740K 16.87K 10.50K
YoY Change -62.93% 60.67%
NET CHANGE
Cash From Operating Activities -7.740K -16.87K -10.50K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 7.740K 16.87K 10.50K
Net Change In Cash 0.000 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$7.740K -$16.87K -$10.50K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001415813
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-147187
dei Entity Registrant Name
EntityRegistrantName
UN MONDE INTERNATIONAL WORLDWIDE LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-0500896
dei Entity Address Address Line1
EntityAddressAddressLine1
5689 Condor Place
dei Entity Address Address Line2
EntityAddressAddressLine2
Westagate Mall
dei Entity Address City Or Town
EntityAddressCityOrTown
Mississauga
dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L5V 2J4
dei City Area Code
CityAreaCode
905
dei Local Phone Number
LocalPhoneNumber
962-0823
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6493346 shares
CY2022Q3 us-gaap Cash
Cash
0 usd
CY2021Q4 us-gaap Cash
Cash
0 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
0 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2022Q3 us-gaap Assets
Assets
0 usd
CY2021Q4 us-gaap Assets
Assets
0 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16396 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3764 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
79873 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
62308 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
96269 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
66072 usd
CY2022Q3 us-gaap Liabilities
Liabilities
96269 usd
CY2021Q4 us-gaap Liabilities
Liabilities
66072 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
6493 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
6493 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2317217 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2317217 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2419979 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2389782 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-96269 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-66072 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
15671 usd
CY2021Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
5400 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
27471 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
16875 usd
CY2022Q3 ARMC Other General And Administrative Income Expense
OtherGeneralAndAdministrativeIncomeExpense
-203 usd
CY2021Q3 ARMC Other General And Administrative Income Expense
OtherGeneralAndAdministrativeIncomeExpense
3203 usd
ARMC Other General And Administrative Income Expense
OtherGeneralAndAdministrativeIncomeExpense
2726 usd
ARMC Other General And Administrative Income Expense
OtherGeneralAndAdministrativeIncomeExpense
29825 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
15468 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
8603 usd
us-gaap Operating Expenses
OperatingExpenses
30197 usd
us-gaap Operating Expenses
OperatingExpenses
46700 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15468 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8603 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-30197 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-46700 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-15468 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-8603 usd
us-gaap Profit Loss
ProfitLoss
-30197 usd
us-gaap Profit Loss
ProfitLoss
-46700 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15468 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-8603 usd
us-gaap Net Income Loss
NetIncomeLoss
-30197 usd
us-gaap Net Income Loss
NetIncomeLoss
-46700 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.002
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.005
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.005
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.007
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.007
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6493346 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6493346 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7603335 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7603335 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6493346 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6493346 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6867408 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6867408 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-7666 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-7666 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-38097 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-45763 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-8603 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-54366 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-66072 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1872 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-67944 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-12857 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-80801 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15468 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-96269 usd
us-gaap Net Income Loss
NetIncomeLoss
-30197 usd
us-gaap Net Income Loss
NetIncomeLoss
-46700 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12632 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7311 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17565 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39389 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17565 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
39389 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17565 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39389 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zuTH4p4jjleb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Use of estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company’s significant estimates include income taxes provision and valuation allowance of deferred tax assets; the fair value of financial instruments; the carrying value and recoverability of long-lived assets, including the values assigned to an estimated useful lives of computer equipment; and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-ten reverse stock split
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1276487 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1276487 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2419979 usd
CY2022Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
79873 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
62308 usd

Files In Submission

Name View Source Status
0001683168-22-007600-index-headers.html Edgar Link pending
0001683168-22-007600-index.html Edgar Link pending
0001683168-22-007600.txt Edgar Link pending
0001683168-22-007600-xbrl.zip Edgar Link pending
armc-20220930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
unmonde_ex3101.htm Edgar Link pending
unmonde_ex3102.htm Edgar Link pending
unmonde_ex3201.htm Edgar Link pending
unmonde_ex3202.htm Edgar Link pending
unmonde_i10q-093022.htm Edgar Link pending
armc-20220930_cal.xml Edgar Link unprocessable
armc-20220930_def.xml Edgar Link unprocessable
armc-20220930_lab.xml Edgar Link unprocessable
armc-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
unmonde_i10q-093022_htm.xml Edgar Link completed